| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |